[1] 2024 年 06 月 25 日药品批准证明文件送达信息 . Retrieved June 25, 2024. From https://www.nmpa.gov.cn/zwfw/sdxx/sdxxyp/yppjfb/20240625150543149.html. [2] 拓益速递 | 君实生物特瑞普利单抗用于治疗晚期三阴性乳腺癌患者的新适应症上市申请获受理. Retrieved May 22 , 2023. From https://mp.weixin.qq.com/s/85Fltr9WdDzsaeUZkhf7Uw. [3] Jiang Z, Ouyang Q, Sun T, et al. Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial. Nat Med. 2024;30(1):249-256. doi:10.1038/s41591-023-02677-x.